These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

656 related items for PubMed ID: 17853902

  • 1. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
    Tacken PJ, de Vries IJ, Torensma R, Figdor CG.
    Nat Rev Immunol; 2007 Oct; 7(10):790-802. PubMed ID: 17853902
    [Abstract] [Full Text] [Related]

  • 2. Targeted antigen delivery and activation of dendritic cells in vivo: steps towards cost effective vaccines.
    Tacken PJ, Figdor CG.
    Semin Immunol; 2011 Feb; 23(1):12-20. PubMed ID: 21269839
    [Abstract] [Full Text] [Related]

  • 3. Dendritic cell-based cancer immunotherapies.
    Fujii S, Takayama T, Asakura M, Aki K, Fujimoto K, Shimizu K.
    Arch Immunol Ther Exp (Warsz); 2009 Feb; 57(3):189-98. PubMed ID: 19479202
    [Abstract] [Full Text] [Related]

  • 4. Dendritic cells and their role in cancer immunotherapy.
    Jalili A.
    Iran J Immunol; 2007 Sep; 4(3):127-44. PubMed ID: 17767012
    [Abstract] [Full Text] [Related]

  • 5. Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma.
    Sun K, Wang L, Zhang Y.
    Cell Mol Immunol; 2006 Jun; 3(3):197-203. PubMed ID: 16893500
    [Abstract] [Full Text] [Related]

  • 6. Receptor-mediated delivery of antigens to dendritic cells: anticancer applications.
    Proudfoot O, Apostolopoulos V, Pietersz GA.
    Mol Pharm; 2007 Jun; 4(1):58-72. PubMed ID: 17228857
    [Abstract] [Full Text] [Related]

  • 7. Cancer vaccines for established cancer: how to make them better?
    Andrews DM, Maraskovsky E, Smyth MJ.
    Immunol Rev; 2008 Apr; 222():242-55. PubMed ID: 18364006
    [Abstract] [Full Text] [Related]

  • 8. Dendritic cell-based immunotherapy.
    Osada T, Clay TM, Woo CY, Morse MA, Lyerly HK.
    Int Rev Immunol; 2006 Apr; 25(5-6):377-413. PubMed ID: 17169781
    [Abstract] [Full Text] [Related]

  • 9. Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.
    Cannon MJ, O'Brien TJ, Underwood LJ, Crew MD, Bondurant KL, Santin AD.
    Expert Rev Anticancer Ther; 2002 Feb; 2(1):97-105. PubMed ID: 12113075
    [Abstract] [Full Text] [Related]

  • 10. Dendritic cell vaccines for cancer immunotherapy.
    Timmerman JM, Levy R.
    Annu Rev Med; 1999 Feb; 50():507-29. PubMed ID: 10073291
    [Abstract] [Full Text] [Related]

  • 11. Dendritic cell-based cancer vaccination: quo vadis?
    Dauer M, Schnurr M, Eigler A.
    Expert Rev Vaccines; 2008 Sep; 7(7):1041-53. PubMed ID: 18767953
    [Abstract] [Full Text] [Related]

  • 12. The use of dendritic cells in cancer immunotherapy.
    Nencioni A, Grünebach F, Schmidt SM, Müller MR, Boy D, Patrone F, Ballestrero A, Brossart P.
    Crit Rev Oncol Hematol; 2008 Mar; 65(3):191-9. PubMed ID: 18055210
    [Abstract] [Full Text] [Related]

  • 13. Dendritic cells in cancer immunotherapy - a short review.
    Wojas K, Tabarkiewicz J, Roliński J.
    Folia Morphol (Warsz); 2003 Nov; 62(4):317-8. PubMed ID: 14655109
    [Abstract] [Full Text] [Related]

  • 14. Current issues in dendritic cell cancer immunotherapy.
    López JA, Hart DN.
    Curr Opin Mol Ther; 2002 Feb; 4(1):54-63. PubMed ID: 11885565
    [Abstract] [Full Text] [Related]

  • 15. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK, Stephani J, Schaefer M, Kalay H, García-Vallejo JJ, den Haan J, Saeland E, Sparwasser T, van Kooyk Y.
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [Abstract] [Full Text] [Related]

  • 16. Human dendritic cells: natural adjuvants in antitumor immunotherapy.
    Di Nicola M, Anichini A, Mortarini R, Bregni M, Parmiani G, Gianni AM.
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):265-73. PubMed ID: 10068060
    [Abstract] [Full Text] [Related]

  • 17. Dendritic cells: tools and targets for antitumor vaccination.
    den Brok MH, Nierkens S, Figdor CG, Ruers TJ, Adema GJ.
    Expert Rev Vaccines; 2005 Oct; 4(5):699-710. PubMed ID: 16221071
    [Abstract] [Full Text] [Related]

  • 18. The use of dendritic cells for cancer vaccination.
    Esche C, Shurin MR, Lotze MT.
    Curr Opin Mol Ther; 1999 Feb; 1(1):72-81. PubMed ID: 11249687
    [Abstract] [Full Text] [Related]

  • 19. Dendritic cells in cancer immunotherapy.
    Gunzer M, Grabbe S.
    Crit Rev Immunol; 2001 Feb; 21(1-3):133-45. PubMed ID: 11642600
    [Abstract] [Full Text] [Related]

  • 20. Clinical applications of dendritic cell vaccines.
    Morse MA, Lyerly HK.
    Curr Opin Mol Ther; 2000 Feb; 2(1):20-8. PubMed ID: 11249649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.